News

Amicrobe raises $2.5 million through convertible debt offering

CARLSBAD, CA  -  FEBRUARY 12, 2020 - Amicrobe Inc. closed their fully-subscribed $2.5 million convertible debt offering.  Proceeds from the financing will be used to support Amicrobe’s growth efforts and progress the development of Amicrobe’s two lead product candidates, Amicidin-α Surgical Gel and Amicidin-β Solution. In addition, this capital will support company operations as Amicrobe undertakes its next equity financing.

3142 Tiger Run Court - Suite 101, Carlsbad, California 92010

+1 (888) 490-1180